Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases
Friday, July 26, 2013 - 09:00
in Health & Medicine
Scientists report an advance toward "structure-based drug design," with the potential to delay or treat Alzheimer's disease, Parkinson's disease, type II diabetes, ALS (also known as Lou Gehrig's disease) and many other degenerative diseases.